ENTERA BIO LTD. Income Tax Expense Continuing Operations
ENTERA BIO LTD. (ENTX) reported Income Tax Expense Continuing Operations of $40.00 thousand for the 3-month period ending 2021-06-30, per its 6-K filed 2021-08-16.
Discontinued › Expense Statement
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2021-08-16
- ENTERA BIO LTD. income tax expense continuing operations for the quarter ending 2021-06-30 was $40.00K.
- ENTERA BIO LTD. income tax expense continuing operations for the quarter ending 2020-06-30 was $0.00.
| Period end | Income Tax Expense Continuing Operations 3 month | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 12 month |
|---|---|---|---|
| 2021-06-30 | $40.00K 6-K · filed 2021-08-16 | $78.00K 6-K · filed 2021-08-16 | |
| 2020-12-31 | $20.00K 20-F · filed 2021-03-18 | ||
| 2020-06-30 | $0.00 6-K · filed 2021-08-16 | $0.00 6-K · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |